
|Articles|July 25, 2018
Novartis Partners with SHYFT
Advertisement
SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.
Novartis will use the following SHYFT solutions:
- STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources
- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How New Technologies Are Impacting the Vaccine Market
2
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
3
Kardigan Planning for $350 Million IPO Raise: Report
4
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
5




